Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up

Table 2 Events and newly diagnosed co-morbidities during follow-up

	Patients with a 2 year FU*
	Total patients (n)	% of those with FU
Death	75/3058	2.5
Macrovascular complications	94/2979	3.2
CAD	24/2979	0.8
Stroke/TIA	42/2979	1.4
PAD	37/2979	1.2
Microvascular complications	355/2979	11.9
Any retinopathy	98/2979	3.3
Any nephropathy	3/2979	0.1
Any neuropathy	305/2979	10.2
Amputation	9/2979	0.3
HF	128/2979	4.3
Non-fatal events combined	490/2979	18.5
All events	565/3058	18.5

Legend: *Including those that died during follow-up; CAD, coronary artery disease; TIA, transitory ischaemic attack; PAD, peripheral artery disease; HF, heart failure; FU, follow-up.

ISSN: 1471-2261